TipRanks
Go Ultimate55% OFF

Simon Read Insider Profile

4 Followers

Simon Read, Director at Dianthus Therapeutics, holds 0.00 shares in Dianthus Therapeutics (Ticker: DNTH), holds 0.00 shares in Ra Pharmaceuticals (Ticker: RARX).

Simon Read's Trading History

DNTH
Dianthus Therapeutics
Aug 19, 2026DirectorUninformative Buy51.00K$0.00
RARX
Ra Pharmaceuticals
Apr 03, 2020―Uninformative Sell604.56K$0.00

You May Also Like

Simon Read insider profile FAQ

What stocks does Simon Read hold?
Simon Read holds: DNTH, RARX stocks.
What was Simon Read’s latest transaction?
Simon Read’s latest transaction was an Uninformative Buy of $51.00K.
What is Simon Read's role in Dianthus Therapeutics?
Simon Read's role in Dianthus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.